NYSEArca - Delayed Quote USD

SPDR S&P Biotech ETF (XBI)

91.18 -1.41 (-1.52%)
At close: May 17 at 4:00 PM EDT
91.21 +0.03 (+0.03%)
After hours: May 17 at 7:58 PM EDT

Performance Overview: XBI

Trailing returns as of 5/17/2024. Category is Health.

YTD Return

XBI
2.12%
Category
0.45%

1-Year Return

XBI
6.37%
Category
1.63%

3-Year Return

XBI
10.36%
Category
3.64%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
XBI
Category
YTD
-5.32%
-0.45%
1-Month
-11.07%
-6.40%
3-Month
-3.44%
-0.75%
1-Year
5.34%
1.63%
3-Year
-14.80%
-3.64%
5-Year
-0.10%
6.68%
10-Year
7.29%
8.71%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
XBI
Category
2023
7.60%
3.22%
2022
-25.87%
-15.16%
2021
-20.45%
6.88%
2020
48.33%
27.63%
2019
32.56%
26.23%
2018
-15.27%
-0.40%
2017
43.77%
24.31%
2016
-15.45%
-10.60%

2015
-62.21%
8.05%
2014
43.80%
27.25%
2013
48.20%
48.17%
2012
32.49%
21.55%
2011
5.26%
7.66%
2010
17.60%
8.38%
2009
-0.04%
22.48%
2008
-9.15%
-23.43%
2007
28.78%
9.27%

ETF Summary

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

ETF Overview

Category Health
Fund Family SPDR State Street Global Advisors
Net Assets 6.36B
YTD Daily Total Return 2.12%
Yield 0.02%
Legal Type Exchange Traded Fund

Related Tickers